AU5539899A - Novel triazolo(4,5-(d))pyrimidine compounds - Google Patents

Novel triazolo(4,5-(d))pyrimidine compounds

Info

Publication number
AU5539899A
AU5539899A AU55398/99A AU5539899A AU5539899A AU 5539899 A AU5539899 A AU 5539899A AU 55398/99 A AU55398/99 A AU 55398/99A AU 5539899 A AU5539899 A AU 5539899A AU 5539899 A AU5539899 A AU 5539899A
Authority
AU
Australia
Prior art keywords
pyrimidine compounds
novel triazolo
triazolo
novel
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55398/99A
Other languages
English (en)
Inventor
Brian Springthorpe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Pharmaceuticals Ltd
Original Assignee
Astra Pharmaceuticals Ltd
Astra Pharmaceutical Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharmaceuticals Ltd, Astra Pharmaceutical Products Inc filed Critical Astra Pharmaceuticals Ltd
Publication of AU5539899A publication Critical patent/AU5539899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU55398/99A 1998-07-17 1999-07-15 Novel triazolo(4,5-(d))pyrimidine compounds Abandoned AU5539899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9802574 1998-07-17
SE9802574A SE9802574D0 (sv) 1998-07-17 1998-07-17 Novel compounds
PCT/SE1999/001277 WO2000004021A1 (en) 1998-07-17 1999-07-15 NOVEL TRIAZOLO[4,5-d]PYRIMIDINE COMPOUNDS

Publications (1)

Publication Number Publication Date
AU5539899A true AU5539899A (en) 2000-02-07

Family

ID=20412117

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55398/99A Abandoned AU5539899A (en) 1998-07-17 1999-07-15 Novel triazolo(4,5-(d))pyrimidine compounds

Country Status (7)

Country Link
EP (1) EP1097153B1 (https=)
JP (1) JP2003519080A (https=)
AT (1) ATE251162T1 (https=)
AU (1) AU5539899A (https=)
DE (1) DE69911785T2 (https=)
SE (1) SE9802574D0 (https=)
WO (1) WO2000004021A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904129D0 (sv) 1999-11-15 1999-11-15 Astra Pharma Prod Novel compounds
US7504497B2 (en) 2003-10-21 2009-03-17 Inspire Pharmaceuticals, Inc. Orally bioavailable compounds and methods for inhibiting platelet aggregation
AU2004284098B2 (en) 2003-10-21 2009-07-16 Inspire Pharmaceuticals, Inc. Tetrahydro-furo [3,4-d] dioxole compounds and compositions and method for inhibiting platelet aggregation
US7335648B2 (en) 2003-10-21 2008-02-26 Inspire Pharmaceuticals, Inc. Non-nucleotide composition and method for inhibiting platelet aggregation
GB2422782A (en) 2003-10-21 2006-08-09 Inspire Pharmaceuticals Inc Non-nucleotide compositions and method for treating pain
US7749981B2 (en) 2003-10-21 2010-07-06 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
US7932376B2 (en) 2005-05-05 2011-04-26 Inspire Pharmaceuticals, Inc. Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
JP2010508350A (ja) 2006-10-31 2010-03-18 ヤンセン ファーマシューティカ エヌ．ベー． Ａｄｐｐ２ｙ１２レセプターアンタゴニストとしてのトリアゾロピリミジン誘導体
WO2015162630A1 (en) * 2014-04-25 2015-10-29 Anlon Chemical Research Organization Novel processes for preparing triazolo [4,5-d]- pyrimidines, including ticagrelor, vianew intermediates and new route of synthesis.
AR107928A1 (es) 2016-03-22 2018-06-28 Merck Sharp & Dohme Moduladores alostéricos de receptores de acetilcolina nicotínicos
CN111116592A (zh) * 2019-11-27 2020-05-08 杭州沧海帆医药科技有限公司 嘧啶并三氮唑类化合物及其医药用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199800019T1 (xx) * 1995-07-11 1998-05-21 Astra Pharmaceuticals Limited Trombosit topaklanmas�n� �nleyici yeni maddeler.
EP0929218A4 (en) * 1996-10-30 2001-05-16 Univ North Carolina P2Y RECEPTOR ANTAGONISTS
EP0946561B1 (en) * 1996-12-20 2002-02-13 AstraZeneca AB Triazolo(4,5-d)pyrimidinyl derivatives and their use as medicaments
SE9702772D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds

Also Published As

Publication number Publication date
EP1097153B1 (en) 2003-10-01
SE9802574D0 (sv) 1998-07-17
JP2003519080A (ja) 2003-06-17
DE69911785T2 (de) 2004-07-29
ATE251162T1 (de) 2003-10-15
DE69911785D1 (de) 2003-11-06
EP1097153A1 (en) 2001-05-09
WO2000004021A1 (en) 2000-01-27

Similar Documents

Publication Publication Date Title
UA66801C2 (uk) Триазоло[4,5-d]піримідинові сполуки, спосіб їх одержання (варіанти), фармацевтична композиція на їх основі та спосіб лікування порушень агрегації тромбоцитів
AU2002305143A1 (en) Pyrazolo'1,5-a!pyridine derivatives
MY121867A (en) Novel triazolo(4,5-d)pyrimidine compounds.
TR200000151T2 (tr) Yeni bileşimler.
AU2002239344A1 (en) Pyrazolopyridines
AU2003228770A1 (en) Substituted pyrazolopyrimidines
CA2274464A1 (en) Ketobenzamides as calpain inhibitors
HK1038744A1 (zh) 用於治療炎性疾病的化合物
IL140093A0 (en) Glycopeptide derivatives and pharmaceutical compositions containing the same
BG103417A (en) Condensed pyrimidine bicyclic derivatives
CA2338600A1 (en) Novel thiazolopyrimidine compounds
SG135965A1 (en) New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
AU2002239348A1 (en) Pyrazolopyridine derivatives
NO20000313L (no) Nye forbindelser
AU1428801A (en) Novel (1,2,3)-triazolo(4,5-D)pyrimidine compounds
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
AU2003217712A1 (en) Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them
AU5539899A (en) Novel triazolo(4,5-(d))pyrimidine compounds
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
AU2002248531A1 (en) Pyrazolopyriadine derivatives
AU2002214467A1 (en) Novel compounds
CA2328832A1 (en) Processes for preparing pesticidal intermediates
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use
AU2002212941A1 (en) Novel compounds
WO2000075158A3 (en) NOVEL 6-PHENYLPURINE 9-β-D-RIBONUCLEOSIDES WITH ANTINEOPLASTIC ACTIVITY, THEIR USE FOR PREPARING PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 14, NO 17, PAGE(S) 3249-3254 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 50438/99 AND 55398/99

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase